149 related articles for article (PubMed ID: 32844190)
21. Silencing of FUS in the common marmoset (Callithrix jacchus) brain via stereotaxic injection of an adeno-associated virus encoding shRNA.
Endo K; Ishigaki S; Masamizu Y; Fujioka Y; Watakabe A; Yamamori T; Hatanaka N; Nambu A; Okado H; Katsuno M; Watanabe H; Matsuzaki M; Sobue G
Neurosci Res; 2018 May; 130():56-64. PubMed ID: 28842245
[TBL] [Abstract][Full Text] [Related]
22. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
23. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
24. Frontotemporal lobar degeneration: toward the end of conFUSion.
Frank S; Tolnay M
Acta Neuropathol; 2009 Nov; 118(5):629-31. PubMed ID: 19844730
[No Abstract] [Full Text] [Related]
25. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
[TBL] [Abstract][Full Text] [Related]
26. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
Mann DMA; Snowden JS
Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
[TBL] [Abstract][Full Text] [Related]
27. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
Ishiguro A; Katayama A; Ishihama A
FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
[TBL] [Abstract][Full Text] [Related]
28. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration.
Dormann D; Haass C
Mol Cell Neurosci; 2013 Sep; 56():475-86. PubMed ID: 23557964
[TBL] [Abstract][Full Text] [Related]
29. Implications of the prion-related Q/N domains in TDP-43 and FUS.
Udan M; Baloh RH
Prion; 2011; 5(1):1-5. PubMed ID: 21135580
[TBL] [Abstract][Full Text] [Related]
30. FUS-related proteinopathies: lessons from animal models.
Lanson NA; Pandey UB
Brain Res; 2012 Jun; 1462():44-60. PubMed ID: 22342159
[TBL] [Abstract][Full Text] [Related]
31. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
Le Ber I
Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
[TBL] [Abstract][Full Text] [Related]
32. Molecular and behavioural abnormalities in the FUS-tg mice mimic frontotemporal lobar degeneration: Effects of old and new anti-inflammatory therapies.
de Munter J; Babaevskaya D; Wolters EC; Pavlov D; Lysikova E; V Kalueff A; Gorlova A; Oplatchikova M; Pomytkin IA; Proshin A; Umriukhin A; Lesch KP; Strekalova T
J Cell Mol Med; 2020 Sep; 24(17):10251-10257. PubMed ID: 32667139
[TBL] [Abstract][Full Text] [Related]
33. Very early-onset behavioral variant frontotemporal dementia in a patient with a variant of uncertain significance of a
Aguzzoli CS; Battista P; Hadad R; Ferreira Felloni Borges Y; Schilling LP; Miller BL
Neurocase; 2022 Aug; 28(4):403-409. PubMed ID: 36228146
[TBL] [Abstract][Full Text] [Related]
34. FUS is phosphorylated by DNA-PK and accumulates in the cytoplasm after DNA damage.
Deng Q; Holler CJ; Taylor G; Hudson KF; Watkins W; Gearing M; Ito D; Murray ME; Dickson DW; Seyfried NT; Kukar T
J Neurosci; 2014 Jun; 34(23):7802-13. PubMed ID: 24899704
[TBL] [Abstract][Full Text] [Related]
35. Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins.
Buratti E
Adv Exp Med Biol; 2021; 1281():243-267. PubMed ID: 33433879
[TBL] [Abstract][Full Text] [Related]
36. [The Clinical, Pathological, and Genetic Correlation in Frontotemporal Lobar Degeneration].
Watanabe R; Arai T
Brain Nerve; 2020 Jun; 72(6):575-583. PubMed ID: 32507756
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers in frontotemporal lobar degenerations--progress and challenges.
Hu WT; Trojanowski JQ; Shaw LM
Prog Neurobiol; 2011 Dec; 95(4):636-48. PubMed ID: 21554923
[TBL] [Abstract][Full Text] [Related]
38. Altered mRNP granule dynamics in FTLD pathogenesis.
Bowden HA; Dormann D
J Neurochem; 2016 Aug; 138 Suppl 1():112-33. PubMed ID: 26938019
[TBL] [Abstract][Full Text] [Related]
39. An autopsy case of frontotemporal lobar degeneration with the appearance of fused in sarcoma inclusions (basophilic inclusion body disease) clinically presenting corticobasal syndrome.
Matsumoto A; Suzuki H; Fukatsu R; Shimizu H; Suzuki Y; Hisanaga K
Neuropathology; 2016 Feb; 36(1):77-87. PubMed ID: 26227957
[TBL] [Abstract][Full Text] [Related]
40. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
